Target intelligence / Profile preview

HLCS antisense RNA 1 (HLCS-AS1)

Target
HLCS-AS1
Molecular classification
long non-coding RNA, lncRNA
01

Overview

HLCS antisense RNA 1 (HLCS-AS1) is a long non-coding RNA (lncRNA) gene found in humans, transcribed in the antisense orientation relative to the HLCS (Holocarboxylase synthetase) gene. As of current knowledge, its specific function, molecular mechanisms, and disease associations remain largely uncharacterized, with no established role as a drug target or biomarker. HLCS-AS1 is catalogued as a non-coding RNA gene by major bioinformatic resources but with no experimentally supported protein product or direct therapeutic relevance[3][5][7][9]. No evidence from curated databases or recent literature supports HLCS-AS1 as a receptor, enzyme, transporter, or other canonical drug target. Most available resources confirm its identity as a lncRNA gene, with no synonyms, validated gene function, or established role in disease[3][5][7][9]. There are no recognized interacting drugs, mechanisms of action, or usage as a biomarker or in patient selection, and there are no safety or therapeutic concerns described. If you are seeking a different antisense RNA (such as HNF1A-AS1 or NNT-AS1), please clarify since those have more established biological and disease roles[1][2][4].

Other names
HLCS antisense RNA 1HLCS-AS1
02

Biological functions

Gene expression regulation (antisense RNA function)Potential regulation of HLCS (Holocarboxylase synthetase) gene
03

Disease associations

No definitive disease roles currently described in available databases or major literature

Beyond the preview

Go deeper on HLCS antisense RNA 1 (HLCS-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLCS antisense RNA 1 (HLCS-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call